核醣核酸與疾病模式
RNA and Disease Development
| 節 | 週四 |
|---|---|
B 19:30–20:20 | 核醣核酸與疾病模式 2 節連堂 |
C 20:30–21:20 |
* 根據陽明交大上課時間表所列
RNA, Disease Development, Therapeutic Targets
教師未提供此項資料
無備註
In this course, we provide in-depth exploration of RNA molecules in disease development, in which the biogenesis, post-transcriptional processing as well as the metabolic turnover of RNA molecules will be discussed. This will help the attending students gain insights to the oncogenesis and tissue sig-naling that underpins the key process of disease onset. Moreover, the course will be conducted with a dynamic interaction manner, whereby questions and topics can be raised interruptedly with regard to the lecture content. Profound group discussion and topic presentations were required twice in this class.
Report and Group Discussion
教師未提供此項資料
| 週次 | 主題 |
|---|---|
| 第 1 週 | 20210916 : Introduction |
| 第 2 週 | 20210923 : Disease Feature and Disease Models |
| 第 3 週 | 20210930 : The RNAs and Hallmark Pathways (I) |
| 第 4 週 | 20211007 : The RNAs and Hallmark Pathways (II) 20210916 : Introduction 20210923 : Disease Feature and Disease Models 20210930 : The RNAs and Hallmark Pathways (I) 20211007 : The RNAs and Hallmark Pathways (II) |
| 第 5 週 | 20211014 : The RNA in Cancer |
| 第 6 週 | 20211021 : The RNA in Virus Infection |
| 第 7 週 | 20211028 : The Biogenesis and Post-Transcriptional Processing of RNA |
| 第 8 週 | 20211104 : Ribo-nucleotide Drug Administration and Pharmaceutic Niche |
| 第 9 週 | 20211111 : Group Discussion |
| 第 10 週 | 20211118 : The Development and RNA biology |
| 第 11 週 | 20211125 : Target RNA by Antisense Oligo in Gene Therapy |
| 第 12 週 | 20211202 : RNA Modification and its Enzymes (I) |
| 第 13 週 | 20211209 : RNA Modification and its Enzymes (II) |
| 第 14 週 | 20211216 : Current Scope of RNA Sequencing, from Microarray to Single Cell RNA-seq |
| 第 15 週 | 20211223 : The Carcinogenesis and RNA biology |
| 第 16 週 | 20211230 : Final exam |
| 第 17 週 | 20220106 : The Prospects of RNA Biology in Disease Therapeutics |
| 第 18 週 | 20220113 : Group Discussion |
教師未提供此項資料
- 地點
- 教師未提供此項資料
- 時間
- 教師未提供此項資料
- 聯絡方式
- 教師未提供此項資料